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JONG-DAE LEE, MD, MASUNORI MATSUZAKI, MD, JOHN ROSS, JR., MD, FACC 
La Jolla, California 
The purpose of this study was to test the hypothesis that 
moderately severe exercise-induced regional myocardial 
ischemia can be prevented by combined pharmacologic 
intervention. Eight chronically instrumented dogs were 
studied using an ameroid constrictor to produce critical 
stenosis of the left circumflex coronary artery. The dogs 
were studied during steady state treadmill exercise that 
induced regional myocardial dysfunction (reduced sys•
tolic wall thickening; sonomicrometers) and ischemia 
(reduced subendocardial blood flow; microspheres). 
During a control exercise run, wall thickening in the 
ischemic posterior wall decreased from 21.4 to 13.3% 
whereas subendocardial blood flow failed to increase 
normally (36% ofthat in the normal zone). In the control 
anterior wall, both wall thickening and subendocardial 
blood flow increased significantly during the control run. 
Wall thickness-left ventricular pressure loop areas were 
calculated as an index of regional work; this index in•
creased abruptly with the onset of exercise in both re-
Various pharmacologic agents are currently used success•
fully to treat patients with angina pectoris. Beta-adrenergic 
blockade is effective in improving exercise tolerance by 
limiting heart rate and myocardial contractility (1-3), cal•
cium channel blockers have been useful in treating vaso•
spastic myocardial ischemia (4-6) as well as effort angina 
pectoris (7-11), and nitrates, which reduce left ventricular 
pressure (12-15) and myocardial oxygen consumption (16), 
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gions but became significantly depressed in the ischemic 
region during the steady state exercise. 
Therapy with a combination of atenolol (0.3 mg/kg 
body weight orally), diItiazem (0.3 mg/kg intravenously) 
and isosorbide dinitrate (2.0 mglkg orally) effectively 
prevented regional myocardial ischemia and regional 
dysfunction. After drug therapy, wall thickening in the 
posterior wall increased from 17.3% at rest to 18.8% 
during exercise, and the regional transmural blood flow 
pattern was markedly improved. The initial overshoot 
of the regional work index during exercise was blunted 
by the drug therapy, and at steady state no differences 
between the ischemic and control regions were detected. 
Thus, combined drug therapy can eliminate exercise•
induced regional myocardial ischemic dysfunction 
and appears to normalize the oxygen supply-demand 
imbalance. 
(J Am Coli CardioI1986;7:1036-46) 
have also long been used. Therefore, several pharmacologic 
strategies can be employed to alleviate angina pectoris, each 
using different mechanisms, suggesting the possibility of 
additive effects. 
We have previously developed (17-22) a canine model 
of chronic coronary stenosis that allows study of the relation 
between regional myocardial function and myocardial blood 
flow distribution during exercise-induced regional myo•
cardial dysfunction. Both beta-adrenergic blockade with 
atenolol and use of the calcium channel antagonist diltiazem 
were effective not only in improving regional perfusion, but 
also in reducing severe exercise-induced dysfunction when 
used separately (21,22), and these agents exhibited an ad•
ditive effect in combination (23). In these studies, the isch•
emia observed during control exercise periods was uni•
fonnly very severe and the improvement in blood flow and 
function with the pharmacologic intervention was modest. 
Such severe ischemia may have minimized the potential 
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benefit of these agents. Therefore, in this study, we used a 
model of chronic single vessel coronary stenosis that re•
sulted in less severe ischemia during exercise because of 
greater coronary collateral channel development than that 
observed in previous studies (21-23). Using this model, we 
tested the hypothesis that moderately severe exercise-in•
duced myocardial ischemia can be completely prevented by 
combining beta-adrenergic blockade and calcium channel 
blockade with nitrate therapy. 
In addition, we further investigated the concept of rel•
ative ischemia by calculating the area of left ventricular 
pressure-wall thickness loops as indicators of regional myo•
cardial external work and oxygen demand (24). This ap•
proach allowed documentation of a transient early phase of 
relative ischemia in areas distal to a chronic coronary ste•
nosis during exercise, at a time when inotropic and chron•
otropic states and regional work increase abruptly so that 
oxygen demand exceeds supply. The subsequent decrease 
in regional performance during continued exercise appears 
to provide an ischemia-induced adjustment of inotropic state 
and performance, thereby lessening the oxygen supply-de•
mand imbalance and leading to absolute rather than relative 
ischemia. We found that regional perfusion and work during 
exercise could be normalized by combined drug therapy, 
suggesting normalization of oxygen supply and demand. 
Methods 
The animals in this study were handled according to the 
animal welfare regulations of the University of California, 
San Diego and the protocol was approved by the animal use 
committee of this institution. These regulations are in ac•
cordance with the animal use principles of the American 
Physiological Society. 
Animal model. Eight adult mongrel dogs weighing 28.1 
± 7.5 kg (mean ± SD) were used in this study. Before 
undergoing surgery, each dog was trained to run on a motor•
driven treadmill and to lie quietly on a table. The animals 
were tranquilized with acepromazine maleate (0.05 mg/kg 
body weight, intravenously) and then anesthetized with so•
dium pentobarbital (26 mg/kg, intravenously); further an•
algesia was provided by morphine (0.5 mg/kg, intrave•
nously). A left lateral thoracotomy in the fifth intercostal 
space exposed the pericardium, which was then opened. A 
miniature pressure transducer (Konigsberg P7) and a Tygon 
fluid-filled catheter (internal diameter 1.27 mm, outer di•
ameter 2.29 mm) were introduced into the left ventricle 
through the apex. Left ventricular pressure measured through 
the catheter (Statham P23Db) was used to calibrate the Kon•
igsberg transducer, with zero pressure reference being taken 
at the estimated level of the right atrium with the dog on 
its right side. Silastic catheters (internal diameter 1.57 mm, 
outer diameter 3.18 mm) were inserted into the left atrium 
for injection of microspheres and in the descending thoracic 
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aorta to withdraw reference blood samples during micro•
sphere injections. 
The proximal left circumflex coronary artery was dis•
sected free and a single crystal (10 MHz) Doppler flow probe 
was placed around the vessel. An ameroid constrictor was 
positioned distal to the flow probe. The constrictor, encased 
in a slotted stainless steel ring (width 5 mm, external di•
ameter 8 mm, luminal diameter 2.3 to 3.0 mm), was de•
signed to produce gradual constriction of the coronary artery 
(25) and stimulate the development of collateral vessels 
(20). A pneumatic occlusive cuff was placed distal to the 
ameroid constrictor. 
Two pairs of ultrasonic crystals (5 MHz) were implanted 
in the left ventricular wall for measuring regional wall thick•
ness using standard techniques (26). One crystal (diameter 
2 mm) was inserted obliquely through the myocardium to 
the subendocardium. A second, larger crystal (diameter 8 
mm) was sewn to the epicardium in a position minimizing 
the ultrasonic transit time between the crystals. One pair of 
crystals was implanted in the posterolateral wall such that 
it lay near the center of the left circumflex coronary artery 
perfusion bed. The other pair was implanted in the anterior 
wall near the septum, within the distribution of the left 
anterior descending artery. At necropsy, the position of all 
crystals was confirmed. All subendocardial crystals were 
within the inner third of the ventricular wall and were within 
the transmural projection of the larger, epicardial crystal. 
The pericardium was left open and all wires and catheters 
were brought through intercost&l spaces adjacent to the tho•
racotomy and then run subcutaneously to the dog's back 
where they were exteriorized between the scapulae. The 
chest was closed in layers and the pneumothorax evacuated 
through a chest tube inserted through the sixth intercostal 
space. Antibiotic agents were administered for 3 days post•
operatively. 
Regional myocardial blood flow. The reference with•
drawal method was used to measure regional myocardial 
blood flow in the conscious dogs. The following 15 ILm 
diameter radionuclide-Iabeled microspheres were used: ce•
rium-141 , chromium-51, tin-113, ruthenium-l 03, niobium-
95 and scandium-46 (New England Nuclear). Because of 
its low number of spheres per milliliter, chromium-51 was 
used exclusively for measurement of nonischemic blood 
flow at rest to ensure that an adequate number of spheres 
was delivered to all tissue samples. Otherwise, the radio•
nuclides were used randomly and injected in sufficient quan•
tity (8 to lOx 106) to ensure greater than 400 microspheres 
per tissue sample (0.5 to 1.0 g) (27,28). All microspheres 
were diluted in 10% dextran (with Tween 80) by the man•
ufacturer. Details of the measurement of regional myo•
cardial blood flow in this laboratory have been described 
previously (21-24). Before injecting the first dose of mi•
crospheres, 2 ml of 10% dextran was administered through 
the left atrial catheter to test for sensitivity to this substance, 
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observed in some dogs and associated with temporary hy•
potension. Left ventricular pressure, wall thicknesses de•
termined using ultrasound (Triton Technologies), coronary 
blood flow velocity and the subendocardial electrogram in 
the posterior wall were monitored throughout the reference 
withdrawal period and the microsphere injection to confirm 
a steady state. 
After the study, dogs were anesthetized and killed with 
excess pentobarbital (intravenously). Hearts were removed 
and fixed in 10% formalin to facilitate sectioning. 
Myocardial samples and the reference blood samples 
were placed in a Packard Autogamma Spectrometer (model 
5912) to determine the quantity and energy level of gamma 
radiation. Energy windows were set to correspond to the 
primary energy peak of each isotope used in a given study. 
The number of counts per window attributable to a specific 
radionuclide was determined using a matrix inversion tech•
nique (29). Myocardial blood flow was then calculated by 
using counts in the tissue and counts in the reference arterial 
sample, together with the withdrawal rate (27). Data pre•
sented are corrected for the wet weight of the tissue sample. 
Although only two transmural sections are reported (cor•
responding to the crystal locations), an entire transverse slice 
of the left ventricle was divided into eight transmural sec•
tions to confirm that the ischemic crystal pair was always 
representative of the central ischemic zone. 
Histologic examination. Histologic sections were made 
at the site of the ischemic zone crystal pair to determine 
whether any necrosis resulted from the closure of the ame•
roid occluder. Only the posterior papillary muscle showed 
evidence of ischemic damage in five dogs; crystal sites were 
free of damage not attributable to the minimal damage caused 
by placement of the crystals (30). None of the eight dogs 
showed gross ischemic damage in the ischemic area at nec•
ropsy. Three dogs, however, had focal necrosis restricted 
to the subendocardial third of the myocardium between the 
crystals in the posterior wall. As including data from these 
three dogs did not affect the conclusions of the study, we 
did not exclude them. However, this may explain the rel•
atively low percent systolic wall thjckening reported for 
the ischemic area at rest because the three dogs having 
focal necrosis had a systolic wall thickening of 15.7 ± 1. 0 
at rest. 
Experimental protocol. Beginning 1 week after sur•
gery, all dogs were studied regularly while resting on the 
right side. Left ventricular pressure, wall thickening and 
coronary blood flow velocity were recorded before and dur•
ing a 10 second occlusion of the circumflex artery produced 
by inflating the pneumatic cuff. The subsequent reactive 
hyperemia after release of the cuff was measured as an 
indication of flow velocity reserve and, therefore, the degree 
of stenosis caused by the ameroid occluder (20). When later 
evaluation of the reactive hyperemia response detected a 
peak hyperemic flow velocity of less than approximately 
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130% of the preocclusion value, a treadmill exercise eval•
uation was performed (21). This consisted of a brief run on 
the treadmill at a 5% grade at a speed sufficient to elicit a 
heart rate of greater than 200 beats/min. If ischemic regional 
dysfunction was produced during this trial run, the exper•
iment was performed the same day. If no dysfunction oc•
curred, the experiment was delayed to allow the ameroid to 
constrict further. Exercise studies were performed an av•
erage of 16.7 ± 5.0 days postoperatively. 
Control measurements were made with the dogs standing 
quietly on the treadmill; this included the first microsphere 
Figure 1. Summarized hemodynamic data illustrating heart rate, 
peak systolic left ventricular pressure (PSL VP), end-diastolic left 
ventricular pressure (EDL VP) and left ventricular peak positive 
first derivative of pressure (dP/dt) during rest control (REST), early 
during the exercise bout (5-lOs), at steady state during micros ph ere 
injection (MICROS) and after 10 minutes ofrecovery after the run 
(10 MIN POST). Circles represent average data (n = 8, x ± SD) 
during the control run and open squares represent data during the 
run with drugs. A = atenolol; D = diltiazem; I = isosorbide 
diriitrate. 
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injection for measuring regional blood flow. The dogs were 
then run at the predetermined speed and 5% grade to produce 
decreased wall thickening in the ischemic area. Once a 
steady state was obtained (confirmed by unchanging left 
ventricular pressure and stable regional wall thickening for 
at least 1.5 minutes) a second microsphere injection was 
made, and the dogs continued to run until the 2 minute 
arterial withdrawal was completed. The second microsphere 
injection was made between 2 and 2.5 min~tes into the run 
and the total run time was 4.53 ± 0.57 minutes. 
Data were recorded on a Brush forced ink recorder and 
on! inch (1.27 cm) magnetic tape throughout the run and 
for! hour of recovery. Dogs then were given atenolol (0.3 
mg/kg orally). Two hours after atenolol administration, iso•
sorbide dinitrate (2.0 mg/kg) was given orally. Forty-five 
minutes after nitrate administration, diltiazem (0.3 mg/kg) 
was infused slowly over 5 minutes into the left atrium. Ten 
minutes after diltiazem administration (3 hours after atenolol 
and 1 hour after isosorbide dinitrate), control data for a 
second identical exercise were recorded. Treadmill exercise 
was then performed at the exact speed and grade and for 
the same duration used in the first run. The third microsphere 
injection was made once a steady state was observed. Data 
were again collected throughout the second run and for a ! 
hour recovery period. 
The rationale for the drug administration regimen is based 
on a previous study that found the maximal effect of atenolol 
for the suppression of exercise-induced tachycardia to be 3 
to 4 hours after oral administration (22). Intravenous dil-
CONTROL RUN RUNNING (11 2 km/hr 5% Grade) 
I 
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tiazem in the dosage used was previously shown to be ef•
fective in reducing exercise-induced ischemia and wall dys•
function in conscious dogs (21). Oral isosorbide dinitrate 
was shown to be maximally effective 1 hour after oral 
administration in dogs (18). We have reported previously 
(22) that there is high reproducibility of regional flow, func•
tion and hemodynamics in sequential runs performed 3 hours 
apart in this model when no intervention is used. 
Data analysis. Data recorded on magnetic tape were 
used for subsequent digitization, beat averaging and anal•
ysis. Variables measured were 1) wall thicknesses at end•
diastole (defined as the time coincident with the onset of a 
positive first derivative of left ventricular pressure [dP/dtD 
and end-systole (defined as the maximal systolic thickening 
occurring between peak negative dP/dt and 20 ms before 
peak negative dP/dt), 2) left ventricular peak and end-dia•
stolic pressures, 3) mean blood flow velocity in the circum•
flex artery, 4) left ventricular dP/dt, and 5) heart rate. Wall 
thickening during systole is presented as the percent change 
from the end-diastolic thickness. To facilitate comparisons 
from animal to animal, values for wall thickness were nor•
malized to a 10 mm initial (control at rest) end-diastolic 
thickness by dividing the end-diastolic and end-systolic wall 
thickness values by the control standing end-diastolic wall 
thickness and multiplying by 10. The absolute values of 
end-diastolic wall thickness in the ischemic and control areas 
during control standing conditions were 11. 45 ± 1. 61 and 
10.99 ± 1.28 mm, respectively. 
A PDPIlI/03 computer system was used for digitizing 
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Figure 2. Recordings made from one study shown 
at fast paper speed (100 mm/s) illustrating changes 
in left ventricular pressure, left ventricular first de•
rIvative of pressure (dP/dt) and wall thickness in 
the posterior (ISCHEMIC) wall and in the anterior 
(CONTROL) wall during a control run (top) and 
during a run after atenolol, Isosorbide dinitrate and 
diltiazem (bottom). Wall thickness during systole 
increased during control exercise in the anterior wall 
but exhibited dysfunction in the posterior wall. After 
drug administration, the dysfunction was elimi•
nated. End-diastole (ED) and end-systole (ES) are 
indicated with solid vertical lines. 
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and averaging the recorded data. Twenty consecutive car•
diac cycles were averaged for each rest observation and 10 
beats were used during early exercise. Left ventricular pres•
sure and wall thickness relations were evaluated by com•
puter reconstruction of the pressure-thickness loop and the 
area transcribed by the averaged loop was calculated as an 
index of regional myocardial work. 
Statistical analysis of the difference between control ex•
ercise and exercise after drug administration employed an 
analysis of variance with repeated measures (31). When 
overall between-group differences were detected, Tukey's 
least significant difference test was used to determine 
which means differed significantly (31). Data are reported 
as mean ± SD. 
Results 
Hemodynamics 
The hemodynamic data from eight dogs are presented in 
Figure 1, and an example of the analog signals from one 
study is presented in Figure 2. To facilitate statistical anal•
ysis, only four time points were compared: 1) control, stand•
ing at rest, 2) the initial 5 to 10 seconds of exercise, 3) the 
time of microsphere injection, and 4) 10 minutes after the 
end of the run. Although not included in the statistical com•
parison, the periods before, during and after microsphere 
injection were compared, to document a hemodynamic steady 
state which was carefully confirmed for each run. The only 
hemodynamic effect at rest of administering atenolol, dil•
tiazem and isosorbide dinitrate was a decrease in peak pos•
itive left ventricular dP/dt. During the control run, left ven•
tricular pressure at end-diastole, peak left ventricular pressure, 
heart rate and left ventricular dP/dt all increased above rest 
levels. 
After the drugs were administered, heart rate increased 
with exercise but the increase was reduced compared with 
the control run. Peak left ventricular pressure failed to in•
crease significantly during the run with drugs, and peak 
positive dP/dt increased transiently but was unchanged from 
rest at the time of microsphere injection. 
Myocardial Blood Flow 
Average regional myocardial blood flow data are pre•
sented graphically in Figure 3. A key feature of this animal 
model of exercise-induced regional myocardial dysfunction 
is the observation that during control conditions at rest there 
is no perfusion abnormality in the posterior walL There was 
no difference between the absolute mean blood flow and 
the transmural distribution of flow in the posterior wall and 
that measured in the control anterior wall at rest. 
Control region. During control exercise, blood flow to 
the control area increased uniformly in each transmural layer 
with no change in the ratio of subendocardial to subepicar-
3.0 
~ 20 
.5 
E , 
I 
::s 
~ 1.0 
ENOO/EPt 
• 113± 13 
a 040± 10. 
o OB2± 24t 
lACC Vol 7. No 5 
May 1986.1036-46 
th' [' ~ LiJ L 
! I 1"1 t 
ENOO/EPt 
·II1±22 
a 116 ± 21 
o 114± 2B 
! ' I I ! , I I 
ENDO MID EPI TM 
POSTERIOR WALL 
(ISCHEMIC) 
ENDO MID EPI TM 
ANTERIOR WALL 
(CONTROL, 
Figure 3. All values mean:±: SD; n = 8. *p < 0.01 versus rest; 
repeated measures analysis of variance, tp < 0.01 versus control 
run. Transmural distribution of regional myocardial blood flow 
(RMBF) in the posterior (ISCHEMIC) wall (left) and anterior 
(CONTROL) wall (right). At rest (circles), blood flow was similar 
in the subendocardial (ENDO) and subepicardial (EPI) regions, 
but during the control run (squares) the ischemic wall showed 
marked transmural heterogeneity whereas the control wall showed 
uniform increase in blood flow. During exercise after drug admin•
istration (triangles) blood flow was uniformly lower than during 
the control run in the control region and was not significantly 
different from the flow to the ischemic region. MID = midmyo•
cardium; TM = averaged transmural blood flow; ENDO/EPI = 
ratio of subendocardial to subepicardial blood flow. 
dial flow (Fig. 3). During exercise with atenolol, diltiazem 
and isosorbide dinitrate, blood flow in the anterior control 
wall was slightly increased, but the changes were not sig•
nificantly above the control values at rest and significantly 
reduced from the control exercise bout (Fig. 3). The sub•
endocardial/subepicardial ratio was unchanged from both 
the control at rest and the control run. 
Ischemic region. Duting control exercise, blood flow 
distribution in the ischemic posterior wall was altered mark•
edly. Whereas epicardial transmural blood flow increased 
by 228% during the control run, neither subendocardial nor 
midwall flows increased significantly, resulting in a decrease 
in subendocardial/subepicardial ratio from 1.13 to 0.40. The 
heterogeneity of blood flow in the left ventricle during the 
control run is confirmed by calculating the blood flow to 
the ischemic wall as a percent of the control area blood 
flow. At rest, normalized flow was close to 1.0, confirming 
homogeneous blood flow in each transmural layer. During 
the control run, normalized subendocardial blood flow de•
creased from 1.08 ± 0.23 to 0.36 ± 0.22 mllmin per g 
(wet weight) (p < 0.01) and midmyocardial blood flow 
decreased from 1.14 ± 0.14 to 0.55 ± 0.31 ml/min per g 
(p < 0.01). Normalized subepicardial blood flow was not 
different. 
During exercise after atenoloi, diltiazem and isosorbide 
dinitrate infusion, blood flow in the ischemic area was sim•
ilar to that measured in the control area. There were no 
JACC Vol 7, No.5 
May 1986: 1036--46 
differences in absolute blood flow for any transmural layer 
during the run with drugs compared with control at rest. 
Furthermore, the subendocardial/subepicardial ratio in the 
ischemic area was 0.82, a significant increase from the 
control run and not significantly different from control at 
rest. The normalized blood flow values in the ischemic zone 
confirmed the amelioration of the regional perfusion ab•
normality, with mid wall and subepicardial normalized blood 
flows being 1.08 and 1.09, respectively, during the run with 
drugs. Although normalized subendocardial blood flow (0.78) 
was still slightly less than that during rest, the average 
transmural blood flow was not different from control at rest. 
Regional Myocardial Function 
The recordings in Figure 2 illustrate the changes in wall 
thickening due to exercise during the control run and after 
drug administration; the averaged results are summarized 
graphically in Figure 4 and end-diastolic wall thickness, 
systolic wall thickening and normalized wall thickening 
(percent of control value at rest) are presented in Table 1. 
The area of the wall thickness-left ventricular pressure loop 
40 
40 
• CON RUN 
o A +0+/ RUN 
~t 
X±SO 
N=8 
I , 
REST 5·10s MICROS 10' POST 
Figure 4. *p < 0.05 versus rest, repeated measures analysis of 
variance; **p < 0.01 versus rest; tp < 0.05 versus control run: 
ttp < 0.01 versus control run. Percent changes in wall thickening 
(% WT) during systole in the posterior wall (ISCHEMIC) and 
anterior wall (CONTROL) during a control run (CON RUN) and 
during a run after administration of atenolol, diltiazem and iso•
sorbide dinitrate (A + D + I RUN). Percent wall thickening 
increased in the first 5 to 10 seconds of the control run in the 
posterior wall but was significantly reduced at the microsphere 
injection (MICROS) during steady state exercise. After drug 
administration, percent wall thickening did not decrease during 
the run. In the anterior wall, percent wall thickening increased and 
remained elevated throughout the control run; after drug admin•
istration, percent wall thickening was depressed at rest and throughout 
the run and recovery (n = 8). 10' POST = 10 minutes after end 
of run. 
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calculated from the digitized and averaged data is presented 
in Table 2, with an index of regional minute-work estimated 
by multiplying the loop area by heart rate. 
Control region. During the control run, systolic wall 
thickening increased abruptly with the onset of exercise and 
remained above the rest level throughout the steady state 
period. Wall thickening was 28.0 ± 5.3% at rest, increased 
34% initially and remained 21 % above the rest value 
throughout the run. Wall thickness-left ventricular pressure 
loop area increased by an average of 77% during the initial 
response to exercise and remained markedly greater than 
rest in the steady state. Regional myocardial minute-work 
index behaved similarly (Table 2). 
After the administration of atenolol. isosorbide dinitrate 
and diltiazem. systolic wall thickening at rest was decreased 
by 18% (p < 0.05). With exercise, systolic wall thickening 
failed to increase both in the initial stages of the run and in 
the steady state, and remained below the levels observed 
during the control run. Work indexes were significantly 
depressed after drug administration (Table 2). The response 
to exercise was similar to the control run but at much lower 
values. 
Ischemic region. In all dogs. the ischemic wall exhib•
ited substantial dysfunction during the control run (Table 
I). At rest, systolic wall thickening averaged 21.4%. The 
initial response to exercise was an increase in wall thick•
ening to 27.4%, but at steady state exercise systolic wall 
thickening decreased by 38% from control to 13.3%. Thus, 
the increased systolic wall thickening was transient, giving 
way to dysfunction by 1 minute into the run. This was 
associated with significant elevation (3.0 ± 1. I m V, n = 
6) of the ST segment of a subendocardial electrogram (taken 
from the subendocardial crystal). 
During the control run. the average wall thickness-left 
ventricular pressure loop area, the index of regional work 
per beat, increased initially by 69% but then decreased slightly 
but not significantly below the control rest value during 
steady state exercise (Table 2). The index of regional min•
ute-work (loop area x heart rate) increased over three times 
initially and remained 95% greater than rest during the steady 
state. The increase was due entirely to the increased heart 
rate, as the absolute loop area was not increased. Loop area 
was unchanged because the reduced systolic wall thickening 
was balanced by an increased systolic left ventricular 
pressure. 
After administration of atenolol. isosorbide dinitrate and 
diltiazem. systolic wall thickening in the potentially isch•
emic area at rest was 17.3%. The initial increase in systolic 
wall thickening observed during the control run was elim•
inated in the run with drug therapy. Also, the systolic wall 
thickening observed during the subsequent steady state was 
not significantly reduced from the control value at rest. 
During the run with drugs, systolic wall thickening was 
18.8 ± 6.4% which was 41 % greater (p < 0.05) than the 
value during the control run. ST elevation in the suben-
Table 1. Regional Myocardial Performance During Control Run and Run With Atenolol, 
Diltiazem and Isosorbide Dinitrate (mean ± SD, n = 8) 
Running 
Control area 
EDWT(mm) 
Control 
A+D+I 
p Value 
%WT 
Control 
A+D+I 
p Value 
Norm % WT 
Control 
A+D+I 
p Value 
Ischemic area 
EDWT(mm) 
Control 
A+D+I 
p Value 
%WT 
Control 
A+D+I 
p Value 
Norm % WT 
Control 
A+D+I 
p Value 
Rest 
10.00 
10.02 :!: 0.28 
28.0 :!: 5.3 
22.9 :!: 4.9 
<0.05 
100 
100 
10.00 
9.86 :!: 0.33 
21.4 ± 6.2 
17.3 ± 5.7 
NS 
100 
100 
10 Sec 
10.16 :!: 0.25 
10.02 :!: 0.24 
NS 
37.6 :!: 8.5t 
24.8 :!: 7.4 
<0.01 
134 :!: 19t 
112 :!: 27 
NS 
10.18 :!: 0.30 
9.72 :!: 0.40 
<0.05 
27.4 :±: 11.5* 
20.9 :!: 9.9 
<0.01 
124 :!: 19* 
117 :!: 22 
NS 
MICROS 10 Min 
10.06 :!: 0.39 9.95 :!: 0.16 
9.93 :!: 0.26 10.08 :!: 0.24 
NS NS 
33.8 :!: 5.8t 27.8 :!: 4.3 
24.9 :!: 5.9 22.8 :!: 5.0 
<0.01 <0.05 
120 :!: 18* 103 :!: 6 
108 :!: 14 102 :!: 12 
NS NS 
10.16 ± 0.30 10.02 :!: 0.14 
9.80 :!: 0.35 9.80 :!: 0.17 
<0.05 <0.05 
13.3 :!: 7.3t 18.0 :!: 6.0 
18.8 :!: 6.4 18.8 :!: 4.4 
<0.05 NS 
59 :!: 23t 83 :!: 9 
109 :!: 12 112 :!: 16 
<0.01 NS 
*p < 0.05 vs. rest; tp < 0.01 vs. rest; p Value compares control exercIse bout with drug runs. A + D + 
= run following atenolol, diltiazem and isosorbide dinitrate; Control = control exercise bout; EDWT = 
end-diastolic wall thIckness, normalized to an initIal dimension of 10 mm; MICROS = time of blood flow 
determInation (microsphere injection) dunng steady state exercise; Norm % WT = normalized systolic wall 
thickening presented as percent of resting value; % WT = percent systolic wall thickening; 10 Min = 10 
minutes after cessation of exercise; 10 Sec = initIal response to exercise. 
Table 2. Regional Myocardial Work Indexes During Control Run and Run With Atenolol, 
Diltiazem and Isosorbide Dinitrate (mean ± SD, n = 8) 
Control A + D + I 
Rest 10 Seconds Micros 10 Min Rest 10 Seconds Micros 10 Min 
Wall thickness-L VP 
loop area 
Ischemic region 
x: 287 484t 290 269 194§ 305t§ 232t§ 221§ 
SD 108 228 ISO 95 81 229 100 84 
Control region 
x: 277 489t 382t 268 215§ 272§ 243t§ 234tt 
SD 104 170 164 88 82 163 116 107 
P Value NS NS <0.01 NS NS <0.05 NS NS 
Loop area x HR 
(+ 1,000) 
Ischemic region 
x: 32.9 116.0t 64.0t 34.1 22.I§ 54.4t§ 39.3t§ 25.9§ 
SD 12.4 63.1 35.4 10.6 8.5 52.1 18.4 8.1 
Control regIon 
x: 31.7 116.4t 86.0t 34.8 24.8tt 47.6t§ 41.7t§ 27.4tt 
SD 10.9 47.4 43.5 10.4 92 38.4 20.9 14.2 
P Value NS NS <0.01 NS NS <0.05 NS NS 
tp < 0.01 vs. rest; ttp < 0 05 vs. control; § p < 0.01 vs. control; p value compares ischemic region with 
control region. HR = heart rate; LVP = left ventricular pressure; other abbreviatIOns as in Table I. 
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docardial electrogram observed in the control run was elim•
inated in four of the six dogs in which it was measured and 
reduced by half in the other two. 
Both indexes of regional work were significantly de•
pressed at rest and during exercise after drug administration 
(Table 2). Unlike the control exercise bout, the indexes of 
both work per beat and minute-work showed a reduced 
initial overshoot but remained significantly greater than con•
trol at rest during steady state exercise. The indexes of 
regional work per beat and minute work in the anterior 
control region were not significantly different from the val•
ues obtained for the posterior ischemic region during steady 
state exercise after drug administration. Thus, the marked 
difference between these two regions observed during the 
control run was completely eliminated. 
Discussion 
Patients with coronary artery disease may have normal 
myocardial blood flow and function at rest despite well 
developed coronary lesions, but experience angina pectoris 
and regional myocardial dysfunction on exertion. Treatment 
usually involves the use of agents to reduce myocardial 
oxygen demand. thereby preventing the heart from working 
at a level greater than can be maintained with the restricted 
coronary arterial inflow. This is accomplished by admin•
istering drugs that directly depress myocardial contractility 
during exercise, such as beta-adrenergic blocking agents 
(1-3). Myocardial oxygen requirements can be further re•
strained by blunting the normal chronotropic response to 
exercise by beta-adrenergic blockade or with certain calcium 
channel blocking drugs (32). Negative chronotropic inter•
vention has the secondary advantage of increasing diastolic 
perfusion time, which is particularly important for suben•
docardial perfusion (33). Additionally, myocardial work can 
be reduced indirectly by reducing systemic arterial pressure 
and afterload by means of peripheral vasodilators (12-15). 
Experimental model. These experiments differ in de•
sign from previous studies in our laboratory, in that exercise•
induced ischemia was less severe than in previous studies 
in which subendocardial blood flow fell markedly during 
exercise and percent wall thickening was reduced from ap•
proximately 27% to 4 or 5% and antianginal drugs reduced 
but did not eliminate evidence of ischemia (21-23). We 
had observed in preliminary experiments that pharmacologic 
agents produced more striking effects when ischemia was 
less severe, and therefore a model was used in which only 
moderately severe ischemia was produced during exercise 
(wall thickening 13% during exercise). In order to test the 
hypothesis that ischemia could be prevented by combined 
drug treatment, new observations on transient non-steady 
state responses indicating "relative" ischemia were also 
made using a regional work index. Evidence that ischemia 
was present during exercise in the present experiments is 
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provided by the marked perfusion defect compared with the 
normal region, associated with functional consequences of 
ischemia (reduced regional contractile function to about one•
half the rest level and ST segment elevation on the sub•
endocardial electrogram). 
"Relative" versus "absolute" ischemia. Our data in•
dicate that exercise-induced ischemia and regional wall dys•
function caused by single vessel coronary constriction can 
be prevented by combining atenolol, diltiazem and isosor•
bide dinitrate. Before the therapeutic regimen, exercise 
produced substantial regional subendocardial ischemia and 
moderately severe wall dysfunction. Exercise-induced wall 
dysfunction during the steady state was preceded by a tran•
sient phase of increased wall thickening and regional myo•
cardial work indexes due to tachycardia, increased systolic 
pressure and enhanced contractility, reflecting a state of 
"relative ischemia" in which oxygen requirements ex•
ceeded supply. Thus, total coronary flow is not likely to 
increase appreciably during this period (21-23), and the 
rapid increase of heart rate causes reduction of flow per beat 
(33), so that a marked oxygen supply-demand imbalance 
must occur. At steady state, however, regional wall thick•
ening was reduced below the control value, reducing re•
gional work per beat to a level more compatible with the 
restricted perfusion and thereby representing" absolute isch•
emia" (24) which was maintained for the remainder of the 
run. The fact that the minute work index remained higher 
than control during running with ischemia may result from 
inaccuracy of this index for reflecting regional oxygen de•
mands during regional ischemia, because the pressure com•
ponent of this index is largely developed by nonischemic 
regions of the ventricle, as discussed later. After the admin•
istration of atenolol, diltiazem and isosorbide dinitrate, the 
initial overshoot of function was blunted and regional wall 
thickening did not decrease below rest levels in the steady 
state. This improved function was associated with regional 
myocardial perfusion similar to that in normal regions. Re•
gional work indexes were increased and not significantly 
different from normal regions, indicating correction of the 
oxygen supply-demand imbalance. 
It is tempting to equate the indexes of regional work 
directly with myocardial oxygen consumption, but mechan•
ical heterogeneity throughout the left ventricle during isch•
emia complicates the interpretation of the wall thickness•
left ventricular pressure loop area. First, the pattern of wall 
thickening is altered during ischemia with thinning during 
isovolumetric systole, reduced ejection phase thickening and, 
in most cases, a predominant postejection thickening (Fig. 
1). The late thickening contributes to wall thickness-left 
ventricular pressure loop area, yet it is not clear whether 
such thickening is an active oxygen consuming process or 
merely passive recoil. Second, there is a transmural gradient 
of blood flow and contraction which has a complex effect 
on overall wall thickening and oxygen consumption (34). 
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In addition, there are mechanical interactions between isch•
emic and nonischemic regions that may impose changes in 
regional myocardial stress and wall tension which are im•
measurable with the techniques used in this study, yet may 
contribute significantly to regional myocardial oxygen de•
mand (35). Thus, active pressure development in the cham•
ber by normal regions of the ventricle is transmitted to the 
ischemic region, but may not indicate a comparable systolic 
load on the ischemic zone. Finally, indexes of global ven•
tricular work do not necessarily correlate closely with in•
duced changes of myocardial oxygen consumption in the 
normal heart (36,37), and it is possible that regional loop 
areas that include a component for "internal work" might 
correlate more closely with regional oxygen consumption 
than our index of regional work (37). Despite these limi•
tations, the wall thickness-left ventricular pressure loop area 
provides additional support for the concept of a transient 
relative ischemia early during exercise, when myocardial 
oxygen demand exceeds supply through the stenotic vessel 
and the immature collateral circulation. 
Mechanisms of elimination of ischemia. In this study, 
restricted arterial inflow to the myocardium was associated 
with nonuniform transmural blood flow such that the sub•
endocardium was underperfused. This has been observed 
during acute stenosis of a coronary artery (38,39) or during 
exercise-induced ischemia with chronic coronary stenosis 
(18-24). Increasing intramyocardial pressure from epi•
cardium to endocardium favors subepicardial perfusion (40), 
and addition of exercise tachycardia further compromises 
subendocardial perfusion, as diastolic perfusion time be•
comes restricted (33). Furthermore, tachycardia increases 
myocardial oxygen consumption, causing metabolic vaso•
dilation in the epicardium overlying the ischemic tissue, 
creating what has been referred to as a "transmural steal" 
phenomenon (41,42). The importance of subendocardial 
perfusion for overall wall thickening was demonstrated by 
Gallagher et al. (43). Thus, the effects of restricted perfusion 
depend not only on the absolute amount of transmural blood 
flow but also on its distribution, suggesting that therapeutic 
agents should act to specifically improve subendocardial 
perfusion in the ischemic area. In the present study, the 
elimination of exercise-induced regional dysfunction was 
associated with a nearly normal blood flow pattern across 
the ischemic wall. Drug treatment also eliminated the dif•
ference between control and ischemic regions during ex•
ercise. This can be seen in Figure 5, in which a blood flow•
function relation for the posterior (ischemic) wall is plotted. 
Wall thickening did not increase in either region during 
exercise after drug administration but, importantly, it did 
not decrease in the ischemic region during the steady state, 
as it did during the control run. Because heart rate still 
increased during exercise after the drugs, it is a reasonable 
assumption that myocardial oxygen consumption also in•
creased. 
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Figure 5. Relation between subendocardial nonnalized myo•
cardial blood flow (RMBF) and percent changes in systolic wall 
thickening (% WT) in the posterior (ischemic) wall during the 
control run (CON RUN, squares) and during the run after admin•
istration of the three drugs (A + D + I RUN, triangles). Both 
flow and function were significantly reduced during the control 
run but neither was affected by the run after administration of 
atenolol (A), diltiazem (D) and isosorbide dinitrate (I). 
The overall effect of the pharmacologic regimen can be 
viewed as an equilibration of regional myocardial oxygen 
demand to match improved regional perfusion, and wall 
performance was not compromised to accomplish this equi•
librium. One important effect of the drug intervention was 
to reduce the tachycardia during exercise. Both atenolol and 
diltiazem have a negative chronotropic effect during exer•
cise (21,22), and reduced heart rate improves the relation 
between oxygen supply and demand in several ways. First, 
the overall myocardial oxygen consumption is closely linked 
to heart rate, thereby reducing oxygen demand globally. 
Second, the reduced rate allows for an increased diastolic 
interval which increases diastolic perfusion time, thus en•
hancing subendocardial perfusion (33). Additionally, the 
action of isosorbide dinitrate on ischemic wall thickening 
during exercise does not appear to utilize the mechanisms 
discussed, as it has neither a negative chronotropic nor a 
negative inotropic effect. Kumada et al. (18), studying the 
effect of isosorbide dinitrate in conscious dogs, observed 
decreased left ventricular systolic pressure but no change in 
heart rate, end-diastolic pressure or positive dP/dt at rest. 
During exercise, neither positive dP/dt nor heart rate were 
affected, but left ventricular pressure and heart size during 
systole and at end-diastole were reduced, so that isosorbide 
dinitrate probably improved regional wall thickening in the 
ischemic area by reducing wall stress. In the present study, 
peak systolic left ventricular pressure during exercise with 
atenolol, diltiazem and isosorbide dinitrate was reduced by 
15% compared with the control exercise. No change in end•
diastolic left ventricular pressure was detected after drug 
therapy, although such an effect has been reported previ•
ously in conscious dogs (18), 
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Finally, a direct effect on collateral circulation may have 
increased collateral perfusion to this ischemic area. Naka•
mura et al. (44) reported that after acute occlusion of the 
left anterior descending coronary artery in open-chest dogs, 
diltiazem significantly increased blood flow to the border 
zone but not in the central ischemic area. Franklin et al. 
(45), using conscious dogs, found that diltiazem increased 
blood flow to collateral flow-dependent myocardium during 
pacing-induced regional myocardial ischemia. The use of a 
calcium antagonist may also improve the transmural blood 
flow distribution. Bache and Tockman (41) reported that 
nifedipine limited the redistribution of blood flow away from 
the subendocardium to the subepicardium during coronary 
artery stenosis. Therefore, calcium antagonists may improve 
regional myocardial function by directly increasing collat•
eral blood flow or by reducing transmural steal. Isosorbide 
dinitrate could also have directly altered coronary perfusion. 
Although nitrates do not appear to reduce coronary vascular 
resistance beyond the normal reduction associated with ex•
ercise (46), they have been shown to dilate large epicardial 
coronary arteries (47). Chiariello et al. (48) reported that 
nitroglycerin can increase regional myocardial blood flow 
to an ischemic region in dogs. Because the dogs in our study 
had collateral-dependent perfusion beds, it is possible that 
isosorbide dinitrate acted on these collateral vessels, which 
are thought to be primarily epicardial. 
Conclusions. This study demonstrates that moderate ex•
ercise-induced regional myocardial dysfunction can be pre•
vented using combined pharmacologic interventions. Our 
data provide a physiologic basis for the clinical use of anti•
anginal agents in combination, in order to take advantage 
of the multiple mechanisms capable of improving ischemic 
myocardial dysfunction. 
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